Improvement of Outcomes in High-risk Myeloma (Optimum/Muknine Trial) | Martin Kaiser | #ASH24
1:10:54
Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of Minnesota
7:47
MRD2STOP: Can multiple myeloma patients stop treatment? | Ben Derman, MD | #ASH24
11:09
Side Effect Severity & Decision-Making Autonomy in Myeloma | Jay Hydren, PhD, CSCS | #ASH24
1:30:57
IMWG Conference Series: Making Sense of Treatment ASH 2024
10:00
Gamma Secretase Inhibition May Boost CAR-T Effectiveness in Some Myeloma | Andrew Portugese | #ASH24
5:32
What are lytic and focal bone lesions and how common are they? #myeloma
16:34
ctDNA: SABCS 2024 - ZEST Trial Cleans Up - Niraparib vs. Placebo in High-Risk Breast Cancer Patients
48:19